Pediatrix Medical
399 hedge funds and large institutions have $6.84B invested in Pediatrix Medical in 2015 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 151 increasing their positions, 116 reducing their positions, and 54 closing their positions.
85% more call options, than puts
Call options by funds: $7.54M | Put options by funds: $4.07M
50% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 54
30% more repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 116
6% more funds holding
Funds holding: 376 → 399 (+23)
4.68% more ownership
Funds ownership: 96.91% → 101.58% (+4.7%)
2% less capital invested
Capital invested by funds: $6.97B → $6.84B (-$137M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
Top Sellers
MD Hedge Fund Activity: Q4 2015 in Review
399 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2015, worth a combined $6.84B — down 2% from $6.97B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new MD positions and 54 closed out — a net gain of 27 holders — while 151 added to existing stakes and 116 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $138M. The largest seller was Bank of New York Mellon, cutting an estimated $85.7M.
- 399 institutional investors held Pediatrix Medical (MD) as of Q4 2015, up from 376 in Q3 2015.
- Funds reported $6.84B of Pediatrix Medical stock for Q4 2015, down 2% quarter-over-quarter.
- 81 funds opened new Pediatrix Medical positions in Q4 2015 and 54 closed out, a net change of +27 holders.
- The largest Pediatrix Medical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $138M added.
- The largest Pediatrix Medical seller in Q4 2015 was Bank of New York Mellon, an estimated $85.7M sold.
Based on aggregated 13F filings for Q4 2015.